Drug
Zp4207 Glucagon Analogue
Zp4207 Glucagon Analogue: highest development phase Phase 2, developed by Zealand Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZP4207(dasiglucagon) glucagon analogue NCT02916251 | Phase 2 | Diabetes Mellitus Type 1 |
Latest
No recent events.
Follow Zp4207 Glucagon Analogue on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.